Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 5.5% on Analyst Downgrade
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price traded down 5.5% on Thursday after JPMorgan Chase & Co. lowered their price target on the stock from $39.00 to $34.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Day One Biopharmaceuticals traded as low as $8.97 and last traded […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price traded down 5.5% on Thursday after JPMorgan Chase & Co. lowered their price target on the stock from $39.00 to $34.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Day One Biopharmaceuticals traded as low as $8.97 and last traded […]
